REBECCA CORCORAN: Open Payments
NPI 1255724712 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 8 payments from 6 companies in 2025. Trend: 2023 $728 · 2024 $341 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $150 |
| Otsuka America Pharmaceutical, Inc. | 1 | $117 |
| Radius Health, Inc. | 1 | $81 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Amgen Inc. | 1 | $15 |
Products named: Ozempic, REXULTI, Tymlos, GIVLAARI, TARPEYO, OTEZLA.
Industry payments across FL — which companies pay providers there.
